Related Experiment Videos

A role for the integrin alphavbeta8 in the negative regulation of epithelial cell growth

S Cambier1, D Z Mu, D O'Connell

  • 1Department of Anatomic Pathology, University of California at San Francisco, 94143, USA.

Cancer Research
|January 13, 2001
PubMed

Insights

Integrin alphavbeta8, absent in lung cancers, inhibits epithelial cell growth and tumor growth in vivo. This discovery reveals integrin alphavbeta8 as a novel growth-regulatory molecule.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Cancer Research

Background:

  • Cell growth is regulated by growth factors and cell-extracellular matrix (ECM) interactions.
  • Integrins are key cell-ECM receptors crucial for cellular responses.
  • While integrin roles in growth promotion are known, integrin-mediated growth inhibition is less understood.

Purpose of the Study:

  • Investigate the role of integrin alphavbeta8 in mediating cell growth inhibition.
  • Determine the mechanism by which integrin alphavbeta8 regulates cell growth.

Main Methods:

  • Expressing integrin beta8 subunit in lung and colon carcinoma cell lines.
  • Utilizing chimeric integrin constructs to analyze the beta8 cytoplasmic domain function.
  • Assessing tumor growth inhibition in vivo using nude mouse models.

Main Results:

  • Integrin beta8 expression inhibited cell growth without inducing apoptosis.
  • Ligation of alphavbeta8 led to cell rounding, reduced focal contacts, and increased p21Cip1 expression.
  • The beta8 cytoplasmic domain alone mediated growth inhibition and cell shape changes.
  • In vivo studies showed potent inhibition of tumor growth by beta8.

Conclusions:

  • Integrin alphavbeta8 acts as a novel growth-regulatory molecule in epithelial cells.
  • The findings suggest alphavbeta8's potential as a therapeutic target for cancers lacking its expression.

Related Concept Videos